UPM Pharmaceuticals, Inc. provides drug development and contract manufacturing services to pharmaceutical and biotechnology industries. Its services include formulation evaluation, such as content uniformity evaluation, dissolution testing, stability assessment, in-vitro bioequivalence determination, powder flow determination, compressibility evaluation, disintegration testing, friability testing, and tap density testing; analytical services, including dissolution testing, stability testing, purity testing, impurity identification, particle size determination, compatibility testing, solubility screening, hygroscopicity studies, methods qualification and validation, protein and peptide based ...
501 5th Street
Bristol, TN 37620
Founded in 1997
UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets
Mar 4 15
UPM Pharmaceuticals has reached an agreement with Sprout Pharmaceuticals to manufacture Flibanserin 100 mg tablets. Sprout has submitted an NDA intending for Flibanserin to be the first drug approved to treat hypoactive sexual desire disorder (HSDD), the most common form of female sexual dysfunction. The tablets will be manufactured at UPM's 475,000 square-foot manufacturing facility in Bristol, Tennessee.
UPM Pharmaceuticals Reaches Agreement with BioPharmX, Inc. to Commercially Manufacture Solid Dose Iodine Supplement Tablets for Consumer Products Sector
Dec 10 14
UPM Pharmaceuticals reached an agreement with BioPharmX, Inc. to commercially manufacture solid dose iodine supplement tablets for the consumer products sector. The tablets will be manufactured at UPM's 475,000 square-foot manufacturing facility in Bristol, Tennessee, under a commercial supply agreement. Terms of the agreement were not disclosed.